Femasys (FEMY) Cash from Operations Growth (3y) (2023 - 2026)
Femasys (FEMY) Cash from Operations Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 70.05% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 16.81% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 53.64% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -9.84% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 13.75% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -33.35% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -8.92% |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | -16.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.10% |
| Dec 31, 2025 | -13.43% |
| Sep 30, 2025 | -25.43% |
| Jun 30, 2025 | -22.29% |
| Mar 31, 2025 | -20.05% |
| Dec 31, 2024 | -31.18% |
| Sep 30, 2024 | -44.85% |
| Jun 30, 2024 | -16.72% |
| Mar 31, 2024 | -57.89% |
| Dec 31, 2023 | -33.68% |
| Sep 30, 2023 | -49.25% |